(Q38011653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Therapeutic live vaccines as a potential anticancer strategy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Farnaz Zahedifard

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

20 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1733-1743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610886%20AND%20SRC:MED&resulttype=core&format=json

Cancer immunotherapy: moving beyond current vaccines

1 February 2020

cites work

1 reference

Tumors as elusive targets of T-cell-based active immunotherapy

21 January 2018

1 reference

Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment

21 January 2018

1 reference

Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors

21 January 2018

1 reference

Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines

21 January 2018

1 reference

Viral vectors as vaccine platforms: deployment in sight

21 January 2018

1 reference

Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts

21 January 2018

1 reference

Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis

21 January 2018

1 reference

A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection

21 January 2018

1 reference

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

21 January 2018

1 reference

Lessons from Coley's Toxin

21 January 2018

1 reference

Can engineered bacteria help control cancer?

21 January 2018

1 reference

Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.

21 January 2018

1 reference

Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.

21 January 2018

1 reference

Advances in imaging gene-directed enzyme prodrug therapy

21 January 2018

1 reference

A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].

21 January 2018

1 reference

The route of enteric infection in normal mice

21 January 2018

1 reference

Salmonellosis: host immune responses and bacterial virulence determinants.

21 January 2018

1 reference

A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice

21 January 2018

1 reference

Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo.

21 January 2018

1 reference

Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent

21 January 2018

1 reference

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

21 January 2018

1 reference

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium

21 January 2018

1 reference

Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma

21 January 2018

1 reference

Attenuated bacteria as effectors in cancer immunotherapy

21 January 2018

1 reference

Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever

21 January 2018

1 reference

Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy

21 January 2018

1 reference

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer

21 January 2018

1 reference

Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.

21 January 2018

1 reference

Survivin minigene DNA vaccination is effective against neuroblastoma

21 January 2018

1 reference

Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.

21 January 2018

1 reference

A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity

21 January 2018

1 reference

Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma.

21 January 2018

1 reference

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

21 January 2018

1 reference

Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth

21 January 2018

1 reference

DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth

21 January 2018

1 reference

Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models

21 January 2018

1 reference

Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies

21 January 2018

1 reference

Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

21 January 2018

1 reference

A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.

21 January 2018

1 reference

Cloning of a functional Salmonella SPI-1 type III secretion system and development of a method to create mutations and epitope fusions in the cloned genes

21 January 2018

1 reference

In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

21 January 2018

1 reference

Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.

21 January 2018

1 reference

Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development

21 January 2018

1 reference

Oral vaccination with attenuated Salmonella enterica strains encoding T-cell epitopes from tumor antigen NY-ESO-1 induces specific cytotoxic T-lymphocyte responses

21 January 2018

1 reference

Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes

21 January 2018

1 reference

Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm

21 January 2018

1 reference

Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.

21 January 2018

1 reference

An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.

21 January 2018

1 reference

Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors

21 January 2018

1 reference

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

21 January 2018

1 reference

High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action

21 January 2018

1 reference

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human

21 January 2018

1 reference

Prodrug converting enzyme gene delivery by L. monocytogenes

21 January 2018

1 reference

Vector delivery methods and targeting strategies for gene therapy of brain tumors

21 January 2018

1 reference

A novel attenuated replication-competent adenovirus for melanoma therapy

21 January 2018

1 reference

MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma

21 January 2018

1 reference

Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium

21 January 2018

1 reference

Introduction: microbiology and immunology: lessons learned from Salmonella.

21 January 2018

1 reference

Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection.

21 January 2018

1 reference

Live bacterial vectors for intranasal delivery of protective antigens.

21 January 2018

1 reference

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

21 January 2018

1 reference

Demonstration of safety of probiotics -- a review

21 January 2018

1 reference

IL-12 and IL-23: master regulators of innate and adaptive immunity.

21 January 2018

1 reference

Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity

21 January 2018

1 reference

A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

21 January 2018

1 reference

An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

21 January 2018

1 reference

Immunologic basis of vaccine vectors

21 January 2018

1 reference

Design and pre-clinical evaluation of a universal HIV-1 vaccine

21 January 2018

1 reference

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys

21 January 2018

1 reference

Vaccine delivery methods using viral vectors

21 January 2018

1 reference

New insights on adenovirus as vaccine vectors

21 January 2018

1 reference

Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.

21 January 2018

1 reference

Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.

21 January 2018

1 reference

A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses

21 January 2018

1 reference

Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.

21 January 2018

1 reference

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

21 January 2018

1 reference

CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

21 January 2018

1 reference

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

Use of attenuated paramyxoviruses for cancer therapy

21 January 2018

1 reference

Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation

21 January 2018

1 reference

Recombinant protein expression in Leishmania tarentolae

21 January 2018

1 reference

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

21 January 2018

1 reference

Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo

21 January 2018

1 reference

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies

21 January 2018

1 reference

Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes.

21 January 2018

1 reference

Trypanosoma cruzi as an effective cancer antigen delivery vector.

21 January 2018

1 reference

Different spectra of therapeutic vaccine development against HPV infections

21 January 2018

1 reference

Improvement of different vaccine delivery systems for cancer therapy

21 January 2018

1 reference

Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.

21 January 2018

1 reference

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

21 January 2018

1 reference

Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress

21 January 2018

1 reference

Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains.

21 January 2018

1 reference

Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses

21 January 2018

1 reference